{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:23:55Z","timestamp":1791278635510,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006756","name":"Brigham Young University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.imlet.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T21:05:31Z","timestamp":1416517531000},"page":"56-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["B cell epitope spreading: Mechanisms and contribution to autoimmune diseases"],"prefix":"10.1016","volume":"163","author":[{"given":"Caleb","family":"Cornaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Mayhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad S.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2014.11.001_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-065X.1998.tb01222.x","article-title":"Determinant spreading: lessons from animal models and human disease","volume":"164","author":"McCluskey","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/375739b0","article-title":"Multiple sclerosis. Presenting an odd autoantigen","volume":"375","author":"Steinman","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2014.11.001_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s001090050092","article-title":"Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis","volume":"75","author":"Bernard","year":"1997","journal-title":"J Mol Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0952-7915(96)80012-4","article-title":"Epitope spreading","volume":"8","author":"Vanderlugt","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2249.2003.02162.x","article-title":"Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide","volume":"132","author":"Thrasyvoulides","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0035","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.4049\/jimmunol.178.4.2565","article-title":"A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading","volume":"178","author":"Deshmukh","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2008.04.019","article-title":"Autoimmunity and oxidatively modified autoantigens","volume":"7","author":"Kurien","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clim.2005.07.002","article-title":"Epitope spreading within lupus-associated ribonucleoprotein antigens","volume":"117","author":"Deshmukh","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0050","doi-asserted-by":"crossref","first-page":"12010","DOI":"10.1073\/pnas.90.24.12010","article-title":"Role of intermolecular\/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles","volume":"90","author":"Fatenejad","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.imlet.2014.11.001_bib0055","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.molimm.2003.11.029","article-title":"Prevention and control of reciprocal T\u2013B cell diversification: implications for lupus-like autoimmunity","volume":"40","author":"Singh","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaut.2008.08.007","article-title":"Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments","volume":"31","author":"Poole","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2014.11.001_bib0065","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2230.2006.02174.x","article-title":"Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid","volume":"31","author":"Maeda","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.143.2.272","article-title":"Clinical evidence of an intermolecular epitope spreading in a patient with pemphigus foliaceus converting into bullous pemphigoid","volume":"143","author":"Peterson","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/329547a0","article-title":"Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site","volume":"329","author":"Milich","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2014.11.001_bib0080","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/art.1780400803","article-title":"Self antigens and epitope spreading in systemic autoimmunity","volume":"40","author":"Craft","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1027328226918","article-title":"T cells of lupus and molecular targets for immunotherapy","volume":"17","author":"Datta","year":"1997","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1084\/jem.20022031","article-title":"The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem)","volume":"197","author":"Li","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0095","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/art.24306","article-title":"Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus","volume":"60","author":"Poole","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/adc.79.5.448","article-title":"Molecular mimicry in autoimmune disease","volume":"79","author":"Leech","year":"1998","journal-title":"Arch Dis Childhood"},{"key":"10.1016\/j.imlet.2014.11.001_bib0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/mab.2012.0076","article-title":"Structure-based peptide mimicry of tumor-associated antigens","volume":"32","author":"Ohtaki","year":"2013","journal-title":"Monoclon Antibod Immunodiagn Immunother"},{"key":"10.1016\/j.imlet.2014.11.001_bib0115","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/374739a0","article-title":"Molecular basis of antigen mimicry by an anti-idiotope","volume":"374","author":"Fields","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2014.11.001_bib0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/jmbi.1996.0629","article-title":"Crystal structure of an Fv-Fv idiotope-anti-idiotope complex at 1.9 A resolution","volume":"264","author":"Braden","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08916930500484849","article-title":"Epstein\u2013Barr virus and molecular mimicry in systemic lupus erythematosus","volume":"39","author":"Poole","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2014.11.001_bib0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-065X.1999.tb01372.x","article-title":"Fc receptor signaling and trafficking: a connection for antigen processing","volume":"172","author":"Amigorena","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/smim.1999.0196","article-title":"Fc receptors for IgG and antigen presentation on MHC class I and class II molecules","volume":"11","author":"Amigorena","year":"1999","journal-title":"Semin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0140","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/cncr.25755","article-title":"B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia","volume":"117","author":"Binder","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.imlet.2014.11.001_bib0145","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.15.1.821","article-title":"Capture and processing of exogenous antigens for presentation on MHC molecules","volume":"15","author":"Watts","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/IMM-120030733","article-title":"The effect of B cell receptor signaling on antigen endocytosis and processing","volume":"33","author":"McGovern","year":"2004","journal-title":"Immunol investig"},{"key":"10.1016\/j.imlet.2014.11.001_bib0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.20011543","article-title":"Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation","volume":"195","author":"Lankar","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0160","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1093\/emboj\/16.12.3553","article-title":"Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen\u2013antibody interaction","volume":"16","author":"Aluvihare","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.imlet.2014.11.001_bib0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0952-7915(98)80037-X","article-title":"Role of B-cell and Fc receptors in the selection of T-cell epitopes","volume":"10","author":"Amigorena","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/1074-7613(95)90118-3","article-title":"Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation","volume":"3","author":"Bonnerot","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2014.11.001_bib0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0952-7915(01)00293-X","article-title":"A closer look at proteolysis and MHC-class-II-restricted antigen presentation","volume":"14","author":"Lennon-Dumenil","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0180","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.193.8.881","article-title":"Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells","volume":"193","author":"Fiebiger","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0185","doi-asserted-by":"crossref","first-page":"14903","DOI":"10.1073\/pnas.95.25.14903","article-title":"In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen","volume":"95","author":"Drakesmith","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.imlet.2014.11.001_bib0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0952-7915(95)80033-6","article-title":"Chemistry of peptides associated with MHC class I and class II molecules","volume":"7","author":"Rammensee","year":"1995","journal-title":"Curr Opin Immunol"},{"issue":"Pt 6","key":"10.1016\/j.imlet.2014.11.001_bib0195","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1242\/jcs.108.6.2337","article-title":"Different endocytic compartments are involved in the tight association of class II molecules with processed hen egg lysozyme and ribonuclease A in B cells","volume":"108","author":"Escola","year":"1995","journal-title":"J Cell Sci"},{"key":"10.1016\/j.imlet.2014.11.001_bib0200","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.158.4.1523","article-title":"Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms","volume":"158","author":"Griffin","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0205","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clim.2012.06.005","article-title":"Characterization of MHC-II antigen presentation by B cells and monocytes from older individuals","volume":"144","author":"Clark","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0210","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1002\/j.1460-2075.1996.tb01083.x","article-title":"Distinct antigen MHC class II complexes generated by separate processing pathways","volume":"15","author":"Lindner","year":"1996","journal-title":"EMBO J"},{"issue":"Pt 2","key":"10.1016\/j.imlet.2014.11.001_bib0215","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1101\/SQB.1977.041.01.068","article-title":"Regulatory mechanisms in the immune response to cell-surface antigens","volume":"41","author":"Lake","year":"1977","journal-title":"Cold Spring Harbor Symp Quantitat Biol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular mechanisms of antibody somatic hypermutation","volume":"76","author":"Di Noia","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.imlet.2014.11.001_bib0225","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.93.5.2019","article-title":"Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease","volume":"93","author":"Ray","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.imlet.2014.11.001_bib0230","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2014.11.001_bib0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2014.11.001_bib0240","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0245","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0250","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0255","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2014.11.001_bib0260","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2523","article-title":"Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination","volume":"10","author":"Kidd","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.imlet.2014.11.001_bib0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jaut.2012.04.005","article-title":"Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading","volume":"39","author":"Prasad","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2014.11.001_bib0270","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.4049\/jimmunol.176.4.2654","article-title":"B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice","volume":"176","author":"Tian","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0275","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2337\/diab.37.3.351","article-title":"Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL\/KsJ db\/db mice","volume":"37","author":"Serreze","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2014.11.001_bib0280","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.4049\/jimmunol.166.8.5265","article-title":"Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes","volume":"166","author":"Brooks-Worrell","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncpneuro0154","article-title":"Immunopathogenesis and immunotherapy of multiple sclerosis","volume":"2","author":"Hemmer","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(98)00063-0","article-title":"Citrullinated myelin basic protein induces experimental autoimmune encephalomyelitis in Lewis rats through a diverse T cell repertoire","volume":"88","author":"Cao","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0295","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-012-1023-3","article-title":"Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response","volume":"124","author":"Kuerten","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0300","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20090299","article-title":"Spontaneous relapsing-remitting EAE in the SJL\/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells","volume":"206","author":"Pollinger","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2014.11.001_bib0310","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/nm1097-1133","article-title":"Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading","volume":"3","author":"Miller","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0315","series-title":"Primer on the rheumatic diseases","author":"Klippel","year":"1997"},{"key":"10.1016\/j.imlet.2014.11.001_bib0320","doi-asserted-by":"crossref","first-page":"e1001311","DOI":"10.1371\/journal.pgen.1001311","article-title":"Risk alleles for systemic lupus erythematosus in a large case\u2013control collection and associations with clinical subphenotypes","volume":"7","author":"Taylor","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.imlet.2014.11.001_bib0325","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0330","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.4049\/jimmunol.168.10.5326","article-title":"Immune responses to small nuclear ribonucleoproteins: antigen-dependent distinct B cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins","volume":"168","author":"Deshmukh","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0335","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molimm.2010.08.003","article-title":"Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes","volume":"48","author":"van Bavel","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0340","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2004.11.001","article-title":"Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading","volume":"38","author":"Scofield","year":"2005","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cei.12094","article-title":"Immunization with 60kD Ro peptide produces different stages of preclinical autoimmunity in a Sjogren's syndrome model among multiple strains of inbred mice","volume":"173","author":"Kurien","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0350","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","article-title":"Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review","volume":"51","author":"Kivity","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2014.11.001_bib0355","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.4049\/jimmunol.175.12.8409","article-title":"Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome","volume":"175","author":"Scofield","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0360","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":"In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0365","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.4049\/jimmunol.168.11.5876","article-title":"HLA class II influences the immune response and antibody diversification to Ro60\/Sjogren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules","volume":"168","author":"Paisansinsup","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0370","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2119\/molmed.2009.00106","article-title":"RNA recognition motif (RRM) of La\/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP","volume":"16","author":"Routsias","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0375","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0380","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1245\/s10434-012-2606-x","article-title":"What is the best definitive treatment for Graves\u2019 disease? A systematic review of the existing literature","volume":"20","author":"Genovese","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0385","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2011.10.005","article-title":"Epidemiology of Graves\u2019 orbitopathy (GO) and relationship with thyroid disease","volume":"26","author":"Lazarus","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.imlet.2014.11.001_bib0390","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1210\/endo.136.10.7664661","article-title":"Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading","volume":"136","author":"Vlase","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.imlet.2014.11.001_bib0395","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/en.2002-0069","article-title":"The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors","volume":"144","author":"Schwarz-Lauer","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.imlet.2014.11.001_bib0400","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/thy.2008.0349","article-title":"Immune response of mice transgenic for human histocompatibility leukocyte Antigen-DR to human thyrotropin receptor-extracellular domain","volume":"19","author":"Inaba","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.imlet.2014.11.001_bib0405","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1210\/en.2013-1033","article-title":"Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides","volume":"154","author":"Inaba","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.imlet.2014.11.001_bib0410","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11926-004-0061-9","article-title":"Antibodies in scleroderma: direct pathogenicity and phenotypic associations","volume":"6","author":"Chung","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.imlet.2014.11.001_bib0415","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/1529-0131(200012)43:12<2733::AID-ANR13>3.0.CO;2-G","article-title":"Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma","volume":"43","author":"Henry","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0420","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1523-1747.2003.12028.x","article-title":"The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis","volume":"120","author":"Asano","year":"2003","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0425","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1023\/A:1020551610319","article-title":"Centrosome proteins: a major class of autoantigens in scleroderma","volume":"19","author":"Gavanescu","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0430","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s10875-009-9339-z","article-title":"Myocarditis: infection versus autoimmunity","volume":"29","author":"Rose","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0435","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0735-1097(10)80331-6","article-title":"Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy","volume":"16","author":"Neumann","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0440","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10741-012-9364-5","article-title":"Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management","volume":"18","author":"Caforio","year":"2013","journal-title":"Heart Failure Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0445","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.imlet.2014.11.001_bib0450","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.106.641472","article-title":"Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives","volume":"115","author":"Caforio","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2014.11.001_bib0455","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2353\/ajpath.2007.060544","article-title":"B-cell epitope spreading is a critical step for the switch from C-protein-induced myocarditis to dilated cardiomyopathy","volume":"170","author":"Matsumoto","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0460","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.1989.81","article-title":"Heymann nephritis: mechanisms of renal injury","volume":"35","author":"Salant","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.imlet.2014.11.001_bib0465","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.2786251","article-title":"Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor","volume":"244","author":"Raychowdhury","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.imlet.2014.11.001_bib0470","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1681\/ASN.2007030342","article-title":"Intramolecular epitope spreading in Heymann nephritis","volume":"18","author":"Shah","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0475","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V6135","article-title":"The Heymann nephritis antigenic complex: megalin (gp330) and RAP","volume":"6","author":"Farquhar","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.2012.374","article-title":"DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats","volume":"83","author":"Wang","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.imlet.2014.11.001_bib0485","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.4049\/jimmunol.171.9.4824","article-title":"DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies","volume":"171","author":"Wu","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0490","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/jid.2013.439","article-title":"A new light on an old disease: adhesion signaling in pemphigus vulgaris","volume":"134","author":"Galichet","year":"2014","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0495","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7861\/clinmedicine.9-4-371","article-title":"Pemphigus: a brief review","volume":"9","author":"Groves","year":"2009","journal-title":"Clin Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0500","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2005.03.005","article-title":"Role of intramolecular epitope spreading in pemphigus vulgaris","volume":"116","author":"Salato","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0505","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archderm.136.5.652","article-title":"Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading?","volume":"136","author":"Bowen","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0510","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.136.5.663","article-title":"Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases","volume":"136","author":"Chan","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0515","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","article-title":"Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia","volume":"24","author":"Stanley","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2014.11.001_bib0520","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","article-title":"Epitope spreading: lessons from autoimmune skin diseases","volume":"110","author":"Chan","year":"1998","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0525","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2014.11.001_bib0530","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0535","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3315\/jdcr.2011.1081","article-title":"Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid","volume":"5","author":"Walmsley","year":"2011","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.imlet.2014.11.001_bib0540","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0545","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2003.12.033","article-title":"A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading","volume":"51","author":"Fairley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0550","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2008.10.061","article-title":"Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting","volume":"61","author":"Recke","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0555","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2014.11.001_bib0560","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clim.2012.03.005","article-title":"Emerging therapies for systemic lupus erythematosus \u2013 focus on targeting interferon-alpha","volume":"143","author":"Lichtman","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0565","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.autrev.2011.08.005","article-title":"Autoimmune disease: a role for new anti-viral therapies?","volume":"11","author":"Dreyfus","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0570","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00403-013-1355-4","article-title":"A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab","volume":"306","author":"Leshem","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.imlet.2014.11.001_bib0575","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kei080","article-title":"B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients","volume":"44","author":"Leandro","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2014.11.001_bib0580","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.27515","article-title":"Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus","volume":"62","author":"Bekar","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2014.08.020","article-title":"The efficacy of novel B cell biologics as the future of SLE treatment: a review","author":"Kamal","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.imlet.2014.11.001_bib0590","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0595","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1517\/14712598.2010.524923","article-title":"Targeting B cells with biologics in systemic lupus erythematosus","volume":"10","author":"La Cava","year":"2010","journal-title":"Exp Opin Biol Ther"},{"key":"10.1016\/j.imlet.2014.11.001_bib0600","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0605","article-title":"A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study","author":"Furie","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2014.11.001_bib0610","article-title":"Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)","author":"Isenberg","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2014.11.001_bib0615","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/art.30373","article-title":"Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0620","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1474-4422(14)70028-6","article-title":"Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial","volume":"13","author":"Kappos","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0625","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.37711","article-title":"Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study","volume":"65","author":"Weinblatt","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0630","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/art.27601","article-title":"The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0635","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.30176","article-title":"Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2014.11.001_bib0640","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","article-title":"The pathogenesis of systemic lupus erythematosus \u2013 an update","volume":"24","author":"Choi","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2014.11.001_bib0650","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/jid.2011.276","article-title":"Demonstration of epitope spreading in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Hashimoto","year":"2011","journal-title":"J Investig Dermatol"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814002557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814002557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:34:32Z","timestamp":1759044872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247814002557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0165247814002557"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2014.11.001","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell epitope spreading: Mechanisms and contribution to autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}